Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Date Title Source
2022-11-30 5:31:34 am Acer Therapeutics Announces $1.5M Private Placement GlobeNewsWire
2022-11-17 2:37:43 am Acer Therapeutics Third Quarter 2022 Earnings: US$0.31 loss per share (vs US$0.23 loss in 3Q 2021) Simply Wall St.
2022-11-14 2:8:0 pm Acer Therapeutics Reports Q3 2022 Financial Results and Provides Corporate Update GlobeNewswire
2022-10-26 5:30:0 am Acer Therapeutics Receives Notice of Allowance of Key US Patent Application Covering EDSIVO™ (celiprolol) GlobeNewswire
2022-10-18 1:5:0 pm SWK Holdings Provides Portfolio Update Highlighting Recent Achievements PR Newswire
2022-10-06 5:30:0 am Acer Therapeutics Announces University of North Carolina Receives Department of Defense Grant to Support the Proposed Investigator Sponsored OASIS Trial of ACER-801 (Osanetant) to Reduce the Frequency and Severity of Post-Traumatic Stress Disorder GlobeNewswire
2022-10-05 10:44:7 am Acer Therapeutics Expands ACER-801 Development Into Post-Traumatic Stress Disorder Benzinga
2022-10-05 5:30:0 am Acer Therapeutics Announces Expansion of ACER-801 (osanetant) Development Indications to Include Post-Traumatic Stress Disorder GlobeNewswire
2022-10-03 5:30:0 am Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate GlobeNewswire